Immediate Release Dissolution Testing

Immediate Release Dissolution Testing is a standardized in vitro pharmaceutical testing method that characterizes the rate and extent of drug release from immediate release dosage forms under controlled conditions, differentiating it from modified release formulations by its focus on rapid disintegration and dissolution within a short timeframe.

69

Publications

2.6K

Citations

308

Authors

111

Institutions

Publications per year

2017–2026

24

Authors

308

  1. VP
    Vinod P. Shah

    Center for Drug Evaluation and Research, United States

    5 publications · 688 citations

    5

    h-index

  2. JD
    Jennifer Dressman

    Goethe University Frankfurt, Germany

    5 publications · 899 citations

    4

    h-index

  3. FK
    Filippos Kesisoglou

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    4 publications · 196 citations

    4

    h-index

  4. CK
    Cynthia K. Brown

    Eli Lilly (United States), United States

    4 publications · 953 citations

    3

    h-index

  5. AG
    Alfredo García‐Arieta

    Agencia Española de Medicamentos y Productos Sanitarios, Spain

    3 publications · 69 citations

    3

    h-index

1–5 of 308

Venues

  1. Dissolution Technologies

    13 publications · 497 citations

    11

    h-index

  2. AAPS PharmSciTech

    8 publications · 631 citations

    8

    h-index

  3. Journal of Pharmaceutical Sciences

    5 publications · 260 citations

    6

    h-index

  4. Pharmaceutics

    3 publications · 110 citations

    4

    h-index

  5. 4

    h-index

1–5